STAT

FEBRUARY 22, 2024

A Florida state policy set amid a measles outbreak in Broward County has vaccination proponents aghast, with many saying it leaves unvaccinated children especially vulnerable to the highly contagious disease. In a letter dated Tuesday about an outbreak at Manatee Bay Elementary School in Weston, located northwest of Miami and west of Fort Lauderdale, the state’s surgeon general, Joseph Ladapo, said that while it is normal policy to tell unvaccinated children to stay home during an outbrea

Vaccines 363

Vaccines 363

Pharmacy Is Right For Me

FEBRUARY 22, 2024

There is a common misconception that all community pharmacies are alike, and that most of what community pharmacists do is count pills. This could not be further from the truth and Dr. Mohanad Znbaqa’s story will demonstrate just how versatile a career practicing in a community pharmacy can be! Expanding Horizons: A Pharmacist’s Journey in Ambulatory Care Dr.

Community Pharmacies 130

Community Pharmacies Scheduling Appointments Diabetes Hospitals 130

STAT

FEBRUARY 22, 2024

When a psychology professor in Michigan looked through his data on interpersonal conflict a decade ago, he discovered something unexpected. The study , which examined differences across cultures and age groups, seemed to show Americans got wiser as they got older. Richard Nisbett was used to research showing poorer mental skills among elderly adults, but his work found they were better at recognizing multiple perspectives, encouraging compromise, and acknowledging the limits of their own knowled

363

363

PharmaVoice

FEBRUARY 22, 2024

Ferring’s U.S. president Brent Ragans discusses the company’s strategy as it expands into new therapeutic areas and further develops its reproductive pipeline.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

FEBRUARY 22, 2024

Imagine having 15 miscarriages. Maybe you can shrug off the first one or two and keep trying to have children, to create a family. But soon every positive pregnancy test brings a sense of dread, of sad inevitability. Your body becomes your enemy.

363

363

PharmaVoice

FEBRUARY 22, 2024

Leading AbbVie to become one of the most successful pharmas in the world, Gonzalez also rubbed some critics the wrong way.

130

130

The Pharmacist

FEBRUARY 22, 2024

Just 52% of pharmacists enjoy ‘some aspects’ of their work or study, a new wellbeing survey from the Royal Pharmaceutical Society (RPS) and charity Pharmacist Support has found. And nearly nine in 10 pharmacists are at high risk of burnout, the survey suggested, prompting calls to address the underlying factors contributing to poor mental health […] The post Only half of pharmacists enjoy their work, survey suggests appeared first on The Pharmacist.

123

123

STAT

FEBRUARY 22, 2024

In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of clinical trials, particularly in oncology. The war put a hold on the vast majority of those studies. But as the country marks two years this week since the invasion — and as the war has dragged on without a clear end in sight — Ukrainian researchers and executives are increasingly urging companies to restart clinical trials, insisting that the advantages that lured drugmakers in the first pl

Drug Development 327

Drug Development 327

BioPharma Dive

FEBRUARY 22, 2024

The startup’s Series C round will support a clinical-stage drug the company thinks could address some of the weaknesses of other KRAS-targeting medicines.

120

120

STAT

FEBRUARY 22, 2024

The U.S. Food and Drug Administration told an advocacy group that it is not planning to take a tougher stance against wayward clinical trial sponsors and investigators that fail to register studies or report results, a central issue in the ongoing debate over greater transparency into clinical research. In response to a citizen’s petition filed a year ago, the agency indicated it is unlikely to levy fines or take a more stringent approach to issue so-called non-compliance notices because

309

309

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

FEBRUARY 22, 2024

Discover how AI, automation, and blockchain technologies are revolutionising pharmaceutical case processing in compliance with FDA regulations. Explore the benefits of these advancements in this insightful article.

109

109

STAT

FEBRUARY 22, 2024

Community Health Systems is facing a new federal probe into its hospital billing practices more than four years after the hospital chain settled separate allegations of fraudulent overbilling. CHS, a national system of 71 rural and suburban hospitals, said this week it received a civil investigative demand from the Department of Justice on Jan. 11. Federal investigators asked CHS to hand over documents that covered “practices and procedures related to utilization review, inpatient admissi

Hospitals 275

Hospitals Inpatient Documentation 275

The Pharmacist

FEBRUARY 22, 2024

Integrated care boards (ICBs) are considering whether to recommend primary care networks (PCNs) switch patients with atrial fibrillation from edoxaban onto apixaban. NHS England advised commissioners last month (16 January) to consider developing a local policy to review direct oral anticoagulant (DOAC) prescriptions among patients. In its commissioning guidance, it stated that clinicians should use the ‘best […] The post ICBs considering advising PCNs to switch patients onto apixaban appe

108

108

STAT

FEBRUARY 22, 2024

After a contentious dispute, Novavax has agreed to refund up to $400 million to the international organization that purchased Covid-19 shots as part of a global vaccination program, but found itself with vaccines that were no longer needed. The agreement caps a disconcerting episode involving several vaccine makers and Gavi, the Vaccine Alliance, a public-private partnership that worked with the World Health Organization as the Covid-19 pandemic erupted four years ago to bring Covid shots to low

Vaccines 270

Vaccines 270

Pharmaceutical Commerce

FEBRUARY 22, 2024

A cohort study investigates how a change in clinical guidelines, an expanded label, and reduction in drug prices can impact the use of PCSK9 inhibitors as a treatment for atherosclerotic cardiovascular disease.

Drug Pricing 104

Drug Pricing Labelling 104

STAT

FEBRUARY 22, 2024

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with. Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software.

Hospitals 270

Hospitals 270

Pharma Times

FEBRUARY 22, 2024

The trial is recruiting patients in Leeds, Manchester, Oxford, London, Cambridge and Kent

Hospitals 131

Hospitals 131

STAT

FEBRUARY 22, 2024

One of us, Jeffrey M., is on weekend call for our office-based internal medicine practice. It is midafternoon, and a patient leaves a message with our answering service — she is concerned about her mother’s respiratory symptoms. So, Jeffrey interrupts his late lunch and rings her back. As she explains that her 96-year-old mother has a harsh cough and nasal congestion, he hears both the facts and the worry in her voice.

Hospitals 262

Hospitals 262

pharmaphorum

FEBRUARY 22, 2024

In a dynamic healthcare market, securing top talent is essential for the success of any organisation. Advanced Clinical looks at innovative recruitment strategies and solutions to help you attract and retain the best healthcare professionals.

97

97

STAT

FEBRUARY 22, 2024

What do CEOs owe the world? Did Humira break the system? And can you CRISPR a fetus? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, former Alnylam Pharmaceuticals CEO John Maraganore and STAT’s Matthew Herper join us to discuss the legacy of AbbVie chief executive Richard Gonzalez, who announced his retirement this week.

224

224

Express Pharma

FEBRUARY 22, 2024

Takeda has decided to discontinue the development programs of its four oncology assets—Phase III asset modakafusp alfa (TAK-573) and three Phase I chimeric antigen receptor (CAR-T) assets: TAK-102, TAK-103 and TAK-940—as part of a plan to align its focus on advancing allogeneic cell therapies. Despite these adjustments, the Japan-based pharma major’s oncology pipeline remains robust, says GlobalData.

Immunity 97

Immunity Immunization 97

STAT

FEBRUARY 22, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, all. Damian here with an update on the plight of the  other  Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

Vaccines 204

Vaccines Drug Pricing Drug Development 204

pharmaphorum

FEBRUARY 22, 2024

NICE has backed NHS use of Pfizer’s Litfulo for patients with alopecia areata, the first drug therapy for a condition that affects around 14,000 people

104

104

STAT

FEBRUARY 22, 2024

Top of the morning to you, and a fine one it is. Clear blue skies are hovering over the Pharmalot campus, where a cool breeze is wafting by and the official mascots are bounding about the grounds in search of critters. As for us, we are engaged in the usual rituals of brewing cups of stimulation — our choice today is orange creme — and foraging for items of interest.

Vaccines 191

Vaccines 191

pharmaphorum

FEBRUARY 22, 2024

On today’s episode of the pharmaphorum podcast, Jason Park, CEO of Empress Therapeutics, discusses his company's novel approach to small molecule drug discovery.

98

98

STAT

FEBRUARY 22, 2024

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. A litmus test for states’ drug pricing power Colorado could soon cap how much the state will pay for Amgen’s autoimmune drug Enbrel — in what would be the first such move from a state prescription drug affordability board.

Drug Pricing 186

Drug Pricing Hospitals 186

pharmaphorum

FEBRUARY 22, 2024

Stay updated on the latest clinical trials happening from 29th January to 2nd February 2024. Explore trials by Vidac, Orion, Revolo Biotherapeutics, and Uvax Bio.

99

99

Pharmaceutical Technology

FEBRUARY 22, 2024

US patients are travelling to avoid abortion bans, but a new study has found telehealth prescriptions to be safe and effective.

111

111

pharmaphorum

FEBRUARY 22, 2024

More digital health consolidation as Aptar buys Healint, a specialist in patient support apps and software to run virtual clinical trials and patient registries

100

100

Outsourcing Pharma

FEBRUARY 22, 2024

The National Institute for Health and Care Excellence (NICE) has issued guidance recommending GSK's Omjjara (momelotinib) as a treatment option for disease-related splenomegaly.

111

111

Express Pharma

FEBRUARY 22, 2024

The Federation of Pharma Entrepreneurs (FOPE) has written a letter to the Ministry of Health & Family Welfare voicing strong concerns over the new Schedule M amendment, and urging the government to reconsider its impact on the sector. The new Schedule M states that manufacturing premises must be exclusively used for the production of drugs, barring any other manufacturing activities.

90

90

Pharmaceutical Technology

FEBRUARY 22, 2024

The company will evaluate an IMC-F106C/Opdivo combination treatment in a Phase III registrational study called PRISM-MEL-301.

105

105

Express Pharma

FEBRUARY 22, 2024

Veerhealth Care, a provider of ayurvedic, herbal and cosmetics healthcare and personal care products under the brand “Ayuveer”, announced its expansion plans with a proposed investment of ₹33 crores. This investment encompasses various aspects including the acquisition of land, construction of buildings, procurement of plant and machinery, and development of essential infrastructure.

89

89

European Pharmaceutical Review

FEBRUARY 22, 2024

A report by Towards Healthcare has forecasted that the advanced drug delivery market will value $375.86 billion by 2033. The year 2023 was “significant” for the progress of advanced drug delivery systems, the author reflected. Last year, with a size of $234.84 billion, the market witnessed “remarkable advancements that promise to reshape healthcare landscapes across the globe”.

86

86

Pharmaceutical Technology

FEBRUARY 22, 2024

The FDA has accepted Regeneron’s biologics licence application (BLA) for linvoseltamab to treat multiple myeloma for priority review.

97

97